Skip to main content

2 Result(s)

within G Verset Remove this filter

and

  1. Article

    Open Access

    DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

    There is an increasing interest for Notch signalling pathway and particularly Delta-like ligand 4 (DLL4) as potential therapeutic target to improve outcome for patients with pancreatic ductal adenocarcinoma (P...

    A Drouillard, F Puleo, J B Bachet, S Ouazzani, A Calomme… in British Journal of Cancer (2016)

    Download PDF (516 KB) View Article

  2. Article

    Open Access

    Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study

    To assess the efficacy of the combination of long-acting release (LAR) octreotide and tamoxifen (TMX) for the treatment of advanced hepatocellular carcinoma (HCC). A total of 109 patients with advanced HCC wer...

    G Verset, C Verslype, H Reynaert, I Borbath, P Langlet… in British Journal of Cancer (2007)

    Download PDF (193 KB) View Article